and krishna by kumar and my doctor and i serve as the director of the new global health innovation center where we're trying to study and to advocate per stronger global access and equity pro-vaccine global stronger asks us in equity for vaccines we should put up front your center does receive funding from pharmaceutical companies in the us is that right it does we work with the public in the private sector including firms in the pharmaceutical sector the gates foundation the u.s. government they receive funding from pfizer johnson and johnson. we receive funding as presented and from there on the by their foundation but we don't do any work that's related to their vaccine development or well ok great thank you question and can tell us a bit about yourself. so the problem i live in bangkok but i could get into a project which works for access to medicines in india brazil and south africa and i've been doing this actually for 18 years and then this in start of the bad i mean i've been looking on increasing access to coronavirus excellence give us a sense of what it's like in india right no

on our top story india's courbet 19 crisis joining us now in the news dr krishna or die a coma director of the global health innovation center he joins us on skype from raleigh in the u.s. state of north carolina dr krishna welcome to the news hour could just talk about one of the issues here with the vaccine is the price point at which it is going through the system point of delivery it seems as if there's no clear across the country strategy in india what's going on. yeah we've reached a point now in india where supplies are extremely constrained there is very little if any importation of vaccine so it's only access to what's domestically produced which normally would be a fairly high level right now it's not keeping up with demand and what's happened with this new phase of vaccinations is allowing both state governments as well as the private sector to buy and to make available vaccines to all adults so what it's really done is created more fragmentation extremely high levels of demand without really increasing supply at all so now i think we will start to see differential pricing we're going to start to see people who ca